Julphar inaugurates drug-making plant in Ethiopia; discusses UAE drug prices

In recognition of the economic importance of Africa and the need for increasingly sophisticated pharmaceutical and healthcare facilities across the continent, United Arab Emirates (UAE)- based Julphar, in conjunction with its local Ethiopian partner, Medtech, last week officially inaugurated its first manufacturing facility in Africa. in Addis Ababa, Ethiopia.

The Julphar Ethiopia manufacturing facility marks a significant milestone in Julphar’s history and is a major part of its international expansion strategy that will see the company building a truly global footprint, the company said. The plant is located in the Gerji Jakros region of the Ethiopian capital.

The pharmaceutical market in Africa is significant and growing, with recent estimates of the continent’s market set at between $8 and $10 billion. In light of this opportunity, Julphar undertook substantial research when developing its Ethiopian facility. The company examined the therapeutic sectors in the country which are limited or inaccessible in order that the Julphar Ethiopia plant would produce relevant and much needed medicines during its production launch phases.